查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1855461

動物生長促進劑市場依產品種類、動物種類、用途、劑型、給藥方法及通路分類－2025-2032年全球預測

Animal Growth Promoters Market by Product Type, Animal Type, Application, Form, Mode Of Administration, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物生長促進劑市場規模將達到 325.7 億美元，複合年成長率為 8.89%。

關鍵市場統計數據
基準年 2024 164.7億美元
預計年份：2025年 179.7億美元
預測年份 2032 325.7億美元
複合年成長率 (%) 8.89%

清晰、權威的指導，將動物生長促進劑置於決策者的監管壓力、消費者期望和運作實際情況之中。

動物生長促進劑處於農業創新、動物健康管理和不斷變化的社會期望的交匯點。這些物質和生物製藥過去常用於提高飼料轉換率、促進生長速度和降低疾病發生率，但如今正面臨日益嚴格的監管審查和不斷變化的消費者偏好。近年來，為了實現永續的生產力和市場認可，業內相關人員不得不重新評估其產品系列、投資重點和供應鏈韌性。

目前，從合成化合物到生物來源的飼料添加劑，各種活性干預措施層出不窮，每種措施都有不同的功效、給藥方式和監管狀態。專家必須權衡其功效與安全性、持久性問題以及抗菌素抗藥性等長期影響。同時，酵素補充劑、植物添加劑、益生元和精準營養等替代方法因其既能提高動物生產性能又能滿足消費者減少抗生素依賴的需求而日益受到關注。

因此，制定產品開發、商業化和市場進入策略需要對科學、監管趨勢、相關人員的期望和分銷動態有全面的了解。透過整體考慮這些方面，企業可以提供既滿足種植者需求又符合公共衛生和永續性目標的產品，從而在複雜的商業環境中創造永續的競爭優勢。

監管、科學和供應鏈韌性的關鍵曲折點正在重塑整個產業的產品開發和商業策略。

近期趨勢正在帶來變革性變化，重新定義動物生長促進劑的研發、監管和在生產系統中的應用方式。首先，監理環境趨於謹慎，政策制定者日益重視公共衛生和環境因素。這一趨勢迫使企業加快非抗生素替代品的創新，並投資於完善的安全性和殘留數據。其次，供應鏈韌性已成為一項策略重點，因為飼料原料和活性物質的供應中斷凸顯了供應鏈的脆弱性，並促使企業更加關注在地採購、配方靈活性和多供應商策略。

第三，微生物組研究和酵素技術的科學進步使得更有針對性的干涉措施成為可能，這些措施無需依賴傳統的抗生素生長促進劑即可改善營養利用率和免疫功能。這些創新與診斷和數據分析技術的進步相輔相成，從而實現了農場層面的精準給藥和性能追蹤。第四，買家和消費者的期望日趨成熟。生產過程的透明度以及關於動物福利和產品安全性的檢驗聲明，如今已成為眾多價值鏈中獲得商業性認可的關鍵。

總而言之，這些變化正在促使研發重點、商業策略和夥伴關係模式進行重新調整。那些將監管前瞻性、科學差異化和供應鏈適應性納入策略規劃的公司，將能夠更好地掌握當前變革帶來的機會；而那些適應緩慢的公司則可能面臨更大的市場和聲譽風險。

2025 年關稅措施如何重塑全球採購優先事項、營運合規負擔以及價值鏈中本地生產的策略獎勵

美國2025年關稅的實施和執行對全球畜牧業供應鏈產生了連鎖反應，迫使製造商、經銷商和生產商調整其採購、定價和庫存策略。出口商和進口商重新調整了供應商關係以減輕關稅的影響，加快了向替代採購市場的多元化發展，並引發了關於關鍵投入品在本土生產和近岸外包的討論。這些調整不僅限於商業性；它們也影響了企業的產品組合決策，因為企業需要評估哪些產品在新成本結構下具有商業性可行性，哪些產品需要重新製造或在地化生產。

此外，關稅引發的摩擦加重了跨境貿易的行政負擔，迫使企業加強海關合規能力並重新談判合約。小型生產商和供應商受到營運複雜性的影響尤其顯著，因為他們難以承擔額外的成本或迅速重組供應鏈。因此，依賴進口中間產品的某些分銷管道和產品形式的銷售成長放緩，需要其他商業策略，例如延長前置作業時間和合併出貨。

同時，貿易夥伴和國內相關人員的政策應對措施包括旨在增強本地生產能力和降低進口依賴性的激勵和支持措施。這些政策轉變鼓勵了配方技術的投資，並促進了目標地區生產規模的擴大。總而言之，2025年關稅的累積影響凸顯了供應鏈敏捷性、合規性和商業性靈活性對於動物生長促進劑生態系統內企業策略的重要性。

提供全面的細分洞察，以明確產品類型、物種特定需求、應用、配方、給藥途徑和通路等方面的策略方向

深入的產品細分有助於在整個動物生長促進劑領域內，針對產品開發、商業性執行和監管規劃進行更精準的策略思考。考慮到Aminoglycosides、大環內酯類、青黴素類、四環黴素類等）、酵素（碳水化合物酶、植酸酶、蛋白酶等）、荷爾蒙（雄性激素、雌激素、黃體素、生長激素等）、植物源性促進生長劑（離子載體、精油、雙叉桿菌萃取、香辛料等）以及益生元（果寡糖、半乳寡糖、甘露聚醣等）等微生物類產品，每種產品都面臨著不同的商業性和監管方面的考量。每類產品都有其自身的證據要求、給藥方案以及獲得獸醫和生產者認可的途徑。

同樣重要的是按動物類型區分，水生動物、牛、家禽和豬的干涉措施需滿足不同的性能預期和法律規範。疾病預防、生長促進和繁殖均需特定的療效資料、安全性監測和給藥策略。劑型（顆粒、液體、丸劑或粉末）的選擇會影響飼料摻入率、穩定性以及農場操作偏好，而給藥方式（飼料添加劑、注射劑或水添加劑）則會影響合規性、勞動力需求和成本結構。

最後，分銷管道的動態至關重要。直銷、分銷商、線上零售平台和獸醫診所的市場管道、服務要求和利潤預期各不相同。整合這些細分維度有助於更精準地進行產品設計、註冊計畫和市場推廣策略，進而提高產品在產業不同細分領域的接受度和商業性成功率。

區域動態和政策細微差別將決定世界主要地區的產品採納、監管合規路徑和商業策略。

區域動態持續對動物生長促進劑的使用演變、監管方式和商業機會產生重大影響。在美洲，政策方針和消費者需求推動了創新和監管，重點關注負責任的使用、可追溯性以及開發符合出口要求的替代品。該地區龐大的一體化生產體係正在推動效率提升和技術應用，而貿易政策的發展則影響著籌資策略和生產佈局。

歐洲、中東和非洲地區法律規範和市場結構的差異導致了不同的應用模式。歐洲司法管轄區往往採用嚴格的核准流程，並優先考慮抗生素管理，從而加速非抗生素解決方案的推廣，並要求提供嚴謹的證據。中東和非洲市場法規環境和需求特徵的多樣性，既帶來了挑戰，也為客製化產品和分銷模式提供了獨特的機會。

亞太地區畜牧業和水產養殖業的快速密集發展，以及不斷演變的監管標準和強勁的消費市場，顯著推動了對性能提升和疾病控制工具的需求。為因應這些動態，本地創新和區域製造能力不斷提升，而貿易政策的波動和投入品供應情況也持續影響商業策略。了解這些區域差異對於優先投資、協調監管文件以及製定符合當地生產者實際情況的分銷和行銷策略至關重要。

傳統監管實力、專業生物技術創新以及市場准入合作模式之間的競爭動態將塑造該領域未來的領導地位。

動物生長促進劑市場的競爭格局呈現出多元化的特點，既有擁有深厚監管經驗的傳統企業，也有專注於生物替代品的利基專家，還有利用微生物組科學和精準營養技術的新興創新者。老字型大小企業規模、監管備案和強大的分銷網路，能夠更廣泛地市場進入，並與一體化生產商和飼料製造商保持持續的合作關係。同時，專注於酵素製劑、植物萃取物、益生元和益生菌的專業公司則憑藉其差異化的功效和與動物福利目標的更緊密契合，經常與飼料整合商和獸醫服務機構合作，以加速產品推廣應用。

創新正變得越來越注重協作，營養品公司、生物技術公司和通路合作夥伴之間正在建立跨行業的夥伴關係，這些合作夥伴能夠將配方專業知識與深刻的客戶洞察相結合。這些夥伴關係有助於加快產品組合的上市速度，並能夠在真實的生產環境中產生更可靠的證據。此外，製造地和供應鏈的可靠性仍然是一項策略差異化因素。能夠確保活性成分和成品配方品質穩定、供應及時的公司將保持競爭力，尤其是在貿易壁壘和原料波動的情況下。

最後，企業策略涵蓋了從加大監管科學領域的投入到進行有針對性的收購，以拓展高成長產品類型的產品組合。對於決策者而言，如何合理配置內部研發、外部合作和通路拓展，將決定能否將科學優勢轉化為商業性效益，同時滿足監管機構和終端消費者日益成長的期望。

產業領導者現在可以採取哪些具有高影響力的策略行動，以確保供應鏈韌性、監管應對力和差異化的商業性價值提案？

產業領導者應優先考慮一系列切實可行的舉措，以平衡短期韌性和長期差異化優勢。首先，加快對替代技術的投資，以減少對傳統抗生素的依賴，並將可靠的療效測試與真實世界的臨床試驗相結合，從而增強獸醫和生產者的信心。其次，加強供應鏈並實現供應商多元化，評估關鍵投入品的離岸生產方案，並實施庫存和物流，最大限度地降低關稅和貿易風險。

第三，增加對監管情報的投入，並積極與監管機構溝通，將簡化核准流程，確保產品聲明在不同司法管轄區均具有說服力。第四，深化與飼料整合商、獸醫服務提供者和數位農業平台的合作，打造將產品與諮詢服務和績效監測結合的捆綁式解決方案。此類整合式解決方案能夠降低農場營運的複雜性，並帶來可衡量的成果，從而加速產品的推廣應用。

第五，加強透明度和認證途徑，以滿足消費者和買家對負責任使用和動物福利的期望。第六，將先進的分析和農場診斷技術融入商業性提案，精準給藥，並在農場層級展現價值。採取這些措施將使企業能夠應對監管方面的挑戰，充分利用科學進步，並在充滿機會和挑戰的環境中滿足相關人員的期望。

採用嚴謹的混合研究途徑，結合專家訪談、監管分析和證據綜合，提供可操作的業界考察。

本執行摘要的研究是基於多方面的證據，以確保分析的全面性和平衡性。關鍵的定性資料包括對價值鏈各環節專家的訪談，涵蓋製劑科學家、法規專家、商業負責人、獸醫和分銷合作夥伴。這些訪談提供了關於產品功效、註冊途徑、市場接受度趨勢和通路經濟效益的實用觀點。二級資訊來源包括同行評審文獻、監管指導文件和技術白皮書，這些資料闡述了與動物生長促進相關的安全性、作用機制和新興技術。

我們的分析方法結合了定性見解的主題綜合分析和對監管環境及貿易政策發展的系統性回顧。我們專注於對不同地區的研究結果進行三角驗證，以識別一致的模式和區域差異。這種方法強調假設的透明度，仔細區分不同產品類別的證據級別，並明確考慮影響產品採用的營運和商業限制。在整個調查方法中，我們力求在科學嚴謹性和對決策者的實際意義之間取得平衡，以滿足其在產品組合策略、監管規劃和市場准入執行方面的需求。

策略總結重點闡述了科學進步、監管變化和供應鏈靈活性將如何決定該領域的競爭優勢。

總體而言，在不斷變化的法規、科學創新以及商業性和消費者期望的推動下，動物生長促進劑市場正在經歷一場變革。傳統的抗生素類生長促進劑正日益受到生物來源的性能增強替代品的競爭，後者承諾在不引發公共衛生問題的情況下提高營養利用率和疾病抵抗力。同時，貿易政策和關稅措施的調整也凸顯了供應鏈彈性和在地化生產方案的戰略重要性。

對於相關人員，未來發展的關鍵在於將科學差異化與穩健的監管策略結合，並建立通路夥伴關係，從而降低農場層面的推廣門檻。那些致力於投資經驗證的替代方案、確保供應鏈多元化並提供產品、諮詢服務和分析相結合的捆綁式解決方案的企業，將能夠更好地掌握商業機遇，同時滿足日益成長的監管和透明度要求。相反，那些僅依賴傳統方法而不適應新的監管和市場現實的公司，則可能面臨營運和聲譽方面的挑戰。未來，那些兼具卓越技術、策略敏捷性和相關人員參與度的企業，必將獲得產業回報。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 利用精準發酵技術生產不含抗生素的牲畜用生物活性生長促進劑
  • 植物性飼料添加劑創新層出不窮，旨在改善單胃動物的腸道健康和生產性能。
  • 開發針對特異性的益生菌配方，以最佳化家禽的營養吸收和免疫反應
  • 抗生素生長促進劑的監管逐步淘汰將推動對替代酶和有機酸解決方案的需求。
  • 將體外輸注技術應用於商品雛雞的早期生長促進和免疫調節。
  • 在各種養殖條件下，擴大採用蛋白質水解物補充劑來改善水產養殖物種的生長指標。
  • 推出多酵素混合物，可提高飼料轉換率並減少牲畜氮磷排泄。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依產品類型分類的動物生長促進劑市場

  • 抗生素
    • Aminoglycosides
    • 大環內酯類
    • 青黴素
    • 四環黴素
  • 酵素
    • 碳水化合物分解酶
    • 植酸酶
    • 蛋白酶
  • 荷爾蒙
    • 雄激素
    • 雌激素
    • 孕酮
    • Somatropin
  • 離子載體
  • 植物源
    • 精油
    • 草藥萃取物
    • 香辛料
  • 益生元
    • 果寡糖
    • 半乳寡糖
    • 甘露聚醣
  • 益生菌
    • 芽孢桿菌
    • 雙歧桿菌
    • 乳酸菌

9. 依動物類型分類的動物生長促進劑市場

  • 水生動物
  • 牛
  • 家禽
  • 豬

第10章：按應用分類的動物生長促進劑市場

  • 疾病預防
  • 促進生長
  • 選育

第11章：動物生長促進劑市場（依劑型分類）

  • 顆粒
  • 液體
  • 顆粒
  • 粉末

第12章：按劑型分類的動物生長促進劑市場

  • 飼料添加劑
  • 注射
  • 水添加物

第13章：依通路分類的動物生長促進劑市場

  • 直銷
  • 經銷商
  • 線上零售
  • 獸醫診所

第14章 按地區分類的動物生長促進劑市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 動物生長促進劑市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國動物生長促進劑市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Archer Daniels Midland Company
    • Cargill, Incorporated
    • BASF SE
    • Koninklijke DSM NV
    • Evonik Industries AG
    • Novus International, Inc.
    • Kemin Industries, Inc.
    • Alltech, Inc.
    • Phibro Animal Health Corporation
    • Nutreco NV
Product Code: MRR-C803CE17101F

The Animal Growth Promoters Market is projected to grow by USD 32.57 billion at a CAGR of 8.89% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.47 billion
Estimated Year [2025] USD 17.97 billion
Forecast Year [2032] USD 32.57 billion
CAGR (%) 8.89%

A clear and authoritative orientation that frames animal growth promoters within regulatory pressures, consumer expectations, and operational realities for decision-makers

Animal growth promoters sit at the intersection of agricultural innovation, animal health management, and evolving public expectations. Historically deployed to improve feed efficiency, accelerate growth rates, and reduce disease incidence, these substances and biologicals have become subject to heightened regulatory scrutiny and shifting consumer preferences. Over recent years, industry actors have been compelled to reassess product portfolios, investment priorities, and supply chain resilience as pathways to sustainable productivity and market acceptance.

The landscape encompasses a diverse set of active interventions, from synthetic compounds to biologically derived feed supplements, each bringing distinct efficacy profiles, administration modes, and regulatory pathways. Practitioners must weigh efficacy against safety, residue concerns, and long-term impacts such as antimicrobial resistance. At the same time, alternative approaches like enzyme supplementation, phytogenic additives, prebiotics, and precision nutrition are gaining attention for their ability to support performance while aligning with consumer demands for reduced antibiotic dependence.

Consequently, strategic planning for product development, commercialisation, and market access requires an integrated understanding of science, regulatory trends, stakeholder expectations, and distribution dynamics. By considering these dimensions together, organisations can position offerings that meet producer needs for performance while addressing public health and sustainability objectives, thereby creating durable competitive advantages in a complex operating environment.

Critical inflection points in regulation, science, and supply chain resilience that are reshaping product development and commercial strategies across the sector

Recent years have produced transformative shifts that are redefining how animal growth promoters are developed, regulated, and adopted across production systems. First, regulatory landscapes have moved toward greater precaution, with policymakers increasingly prioritising public health outcomes and environmental considerations; this trend has forced companies to accelerate innovation in non-antibiotic alternatives and to invest in robust safety and residue data packages. Second, supply chain resilience has become a strategic priority, as disruptions in feed ingredients and active materials have highlighted vulnerabilities and driven interest in local sourcing, formulation flexibility, and multi-supplier strategies.

Third, scientific advances in microbiome research and enzyme technologies are enabling more targeted interventions that improve nutrient utilisation and immune function without relying on traditional antibiotic growth promoters. These innovations are complemented by improved diagnostics and data analytics, which permit precision dosing and performance tracking at the farm level. Fourth, buyer and consumer expectations have matured; transparency in production practices and verifiable claims about animal welfare and product safety are now central to commercial acceptance in many value chains.

Taken together, these shifts are prompting a reconfiguration of R&D priorities, commercial strategies, and partnership models. Firms that integrate regulatory foresight, scientific differentiation, and supply chain adaptability into their strategic plans are better positioned to capture opportunities amid ongoing transformation, while those that delay adaptation may face increasing market and reputational risks.

How 2025 tariff actions recalibrated global sourcing priorities, operational compliance burdens, and strategic incentives for local manufacturing across the value chain

The introduction and escalation of tariffs by the United States in 2025 created a ripple effect across global supply chains that support animal growth promoters, prompting manufacturers, distributors, and producers to adjust sourcing, pricing structures, and inventory practices. Exporters and importers recalibrated supplier relationships to mitigate tariff exposure, which accelerated diversification toward alternative sourcing markets and stimulated conversations about on-shore manufacturing and near-shoring for critical inputs. These adaptations were not solely commercial; they also influenced portfolio decisions as companies evaluated which products remained commercially viable under new cost structures and which required reformulation or localisation.

In addition, tariff-induced friction increased the administrative burden for cross-border transactions, necessitating more robust customs compliance capabilities and contract renegotiations. This operational complexity was felt most strongly by smaller producers and suppliers with limited capacity to absorb added costs or to reconfigure supply chains rapidly. As a result, certain distribution channels and product formats that depend on imported intermediates experienced slower turnover and required alternative commercial tactics, such as longer lead times and consolidated shipments.

At the same time, policy responses from trade partners and domestic stakeholders included incentives and support measures aimed at bolstering local manufacturing capacity and reducing import dependency. These policy shifts encouraged investment into formulation technologies and manufacturing scale-up in target geographies. In sum, the cumulative impact of tariffs in 2025 reinforced the strategic importance of supply chain agility, regulatory compliance, and commercial flexibility for organisations operating within the animal growth promoter ecosystem.

Comprehensive segmentation insights that align product types, species-specific needs, application contexts, formulations, administration routes, and distribution pathways for strategic clarity

Insightful segmentation enables more precise strategic thinking about product development, commercial execution, and regulatory planning across the animal growth promoter domain. When products are considered by type-covering antibiotics such as aminoglycosides, macrolides, penicillins, and tetracyclines; enzymes including carbohydrase, phytase, and protease; hormones spanning androgens, estrogens, progesterones, and somatotropins; ionophores; phytogenics comprising essential oils, herbal extracts and spices; and microbiome-focused options such as prebiotics like fructo oligosaccharides, galacto oligosaccharides, and mannan oligosaccharides alongside probiotics exemplified by Bacillus, Bifidobacterium and Lactobacillus-distinct commercial and regulatory considerations emerge. Each product family implies unique evidence requirements, administration protocols, and pathways to acceptance among veterinarians and producers.

Equally important is differentiation by animal type, where interventions for aquatic animals, cattle, poultry and swine follow divergent performance expectations and regulatory frameworks. Application context further modifies strategic priorities: disease prevention, growth promotion, and reproduction each call for specific efficacy data, safety monitoring, and dosing strategies. Form selection-granules, liquid, pellets and powder-affects feed integration, stability, and on-farm handling preferences, while mode of administration through feed additives, injectables or water additives influences compliance, labor requirements, and cost structures.

Finally, distribution dynamics matter: direct sales, distributors, online retail platforms and veterinary hospitals each offer different routes to market, service requirements, and margin expectations. Integrating these segmentation dimensions enables sharper targeting of product design, registration planning, and go-to-market approaches, thereby increasing the likelihood of adoption and commercial success in distinct subsegments of the industry.

Regional dynamics and policy nuances that determine product adoption, regulatory compliance pathways, and commercial strategies across key global territories

Regional dynamics continue to exert significant influence on the evolution of animal growth promoter use, regulatory approaches, and commercial opportunities. In the Americas, policy approaches and consumer demands have driven both innovation and scrutiny, with a strong emphasis on responsible use, traceability, and the development of alternatives that meet export requirements. This region's large and integrated production systems have incentivised efficiency gains and technological adoption, while trade policy developments have influenced sourcing strategies and manufacturing footprints.

Across Europe, the Middle East and Africa, regulatory frameworks and market structures are heterogeneous, resulting in varied adoption patterns. European jurisdictions tend to apply stringent approval processes and to prioritise antimicrobial stewardship, which has accelerated uptake of non-antibiotic solutions and generated rigorous evidence expectations. Markets in the Middle East and Africa present diverse regulatory environments and demand profiles that create both challenges and niche opportunities for tailored products and distribution models.

In the Asia-Pacific region, rapid intensification of livestock and aquaculture production, coupled with evolving regulatory standards and strong consumer markets, has driven substantial demand for performance-enhancing and disease-management tools. Local innovation and regional manufacturing capacity have expanded in response to these dynamics, while fluctuating trade policies and input availability continue to shape commercial strategies. Understanding these regional nuances is essential for prioritising investment, tailoring regulatory dossiers, and designing distribution and marketing tactics that reflect local producer realities.

Competitive dynamics that blend legacy regulatory strength, specialist biological innovation, and collaborative go-to-market models shaping future leadership in the sector

The competitive landscape of animal growth promoters is characterised by a mix of legacy players with deep regulatory experience, niche specialists focused on biologically derived alternatives, and emerging innovators leveraging microbiome science and precision nutrition. Established firms benefit from scale, regulatory dossiers, and entrenched distribution networks, which facilitate broad market access and ongoing engagement with integrated producers and feed manufacturers. At the same time, specialist companies that concentrate on enzymes, phytogenics, prebiotics, and probiotics are capitalising on differentiated efficacy profiles and stronger alignment with stewardship objectives, often partnering with feed integrators and veterinary services to accelerate adoption.

Innovation is increasingly collaborative, with cross-sector partnerships between nutrition companies, biotechnology firms, and channel partners that can combine formulation expertise with deep customer insights. These partnerships support faster route-to-market for combinations of products and enable more credible evidence generation in real-world production settings. Additionally, manufacturing footprint and supply chain reliability remain strategic differentiators; firms that can assure consistent quality and timely delivery of active ingredients and finished formulations maintain a competitive edge, particularly when trade barriers or raw material volatility are present.

Finally, corporate strategies vary from deepening investments in regulatory science to pursuing targeted acquisitions that broaden portfolios in high-growth product categories. For decision-makers, identifying the right mix of internal R&D, external partnerships, and channel development will determine the capacity to convert scientific advantage into commercial performance while meeting heightened expectations from regulators and end consumers.

High-impact strategic actions that industry leaders can implement now to secure supply resilience, regulatory readiness, and differentiated commercial value propositions

Industry leaders should prioritise a set of actionable initiatives that balance near-term resilience with long-term differentiation. First, accelerate investment in alternative technologies that reduce reliance on traditional antibiotics, pairing robust efficacy studies with real-world trials to build credibility among veterinarians and producers. Second, strengthen supply chain strategies by diversifying suppliers, evaluating near-shore manufacturing options for critical inputs, and instituting inventory and logistics practices that minimise tariff and trade risk exposure.

Third, invest in regulatory intelligence and preemptive engagement with authorities to streamline approvals and to ensure that product claims are defensible across jurisdictions. Fourth, deepen partnerships with feed integrators, veterinary service providers and digital agriculture platforms to create bundled solutions that combine products with advisory services and performance monitoring. These integrated offerings can accelerate adoption by reducing on-farm complexity and by delivering measurable outcomes.

Fifth, enhance transparency and certification pathways that respond to consumer and buyer expectations about responsible use and animal welfare, using validated protocols to substantiate claims. Sixth, embed advanced analytics and on-farm diagnostics into commercial propositions to enable precision dosing and to demonstrate value at the farm level. Executed together, these actions will position organisations to manage regulatory headwinds, to capitalise on scientific progress, and to meet evolving stakeholder expectations in a contested yet opportunity-rich environment.

A rigorous mixed-methods research approach combining expert interviews, regulatory analysis, and evidence synthesis to produce actionable industry insights

The research underpinning this executive summary combines multiple evidence streams to ensure comprehensive and balanced analysis. Primary qualitative inputs included interviews with subject matter experts across the value chain, encompassing formulation scientists, regulatory specialists, commercial leaders, veterinarians, and distribution partners. These conversations provided practical perspectives on product efficacy, registration pathways, adoption dynamics, and channel economics. Secondary sources encompassed peer-reviewed literature, regulatory agency guidance documents, and technical white papers that elucidate safety profiles, mechanisms of action, and emerging technologies relevant to animal growth promotion.

Analytical methods integrated thematic synthesis of qualitative insights with systematic review of regulatory contexts and trade policy developments. Attention was given to triangulating findings from different geographies to identify consistent patterns and region-specific divergences. The approach emphasised transparency in assumptions, careful differentiation between evidence levels across product classes, and explicit consideration of operational and commercial constraints that influence adoption. Throughout, the methodology sought to balance scientific rigor with practical relevance for decision-makers focused on portfolio strategy, regulatory planning, and go-to-market execution.

A strategic closing synthesis highlighting how scientific advancement, regulatory shifts, and supply chain agility will determine competitive advantage in the sector

In aggregate, the animal growth promoter landscape is undergoing a period of purposeful transition driven by regulatory evolution, scientific innovation, and shifting commercial and consumer expectations. Traditional antibiotic-based growth promotion is increasingly juxtaposed with biologically derived and performance-enhancing alternatives that promise improved nutrient utilisation and disease resilience without the same public health concerns. Concurrently, trade policy shifts and tariff actions have underscored the strategic importance of supply chain agility and local manufacturing options.

For stakeholders, the path forward involves integrating scientific differentiation with robust regulatory strategies and channel partnerships that reduce barriers to adoption at the farm level. Organisations that move decisively to invest in validated alternatives, to secure diversified supply chains, and to offer bundled solutions that combine product, advisory services, and analytics will be better positioned to capture commercial opportunities while meeting heightened expectations for stewardship and transparency. In contrast, firms that rely solely on legacy approaches without adapting to emerging regulatory and market realities are likely to encounter increasing operational and reputational challenges. The future of the sector will reward those who combine technical excellence with strategic agility and stakeholder engagement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of precision fermentation techniques to produce antibiotic-free bioactive growth promoters for livestock
  • 5.2. Surge in innovation of phytogenic feed additives to enhance gut health and performance in monogastric animals
  • 5.3. Development of species-specific probiotic formulations to optimize nutrient absorption and immune response in poultry
  • 5.4. Regulatory phase-out of antibiotic growth promoters driving demand for alternative enzyme and organic acid solutions
  • 5.5. Integration of in ovo injection technologies for early-stage growth promotion and immunomodulation in commercial chicks
  • 5.6. Rising adoption of protein hydrolysate-based supplements to improve growth metrics in aquaculture species under varied farming conditions
  • 5.7. Emergence of tailored multi-enzyme blends to improve feed conversion efficiency and reduce nitrogen and phosphorus excretion in livestock

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Growth Promoters Market, by Product Type

  • 8.1. Antibiotics
    • 8.1.1. Aminoglycosides
    • 8.1.2. Macrolides
    • 8.1.3. Penicillins
    • 8.1.4. Tetracyclines
  • 8.2. Enzymes
    • 8.2.1. Carbohydrase
    • 8.2.2. Phytase
    • 8.2.3. Protease
  • 8.3. Hormones
    • 8.3.1. Androgens
    • 8.3.2. Estrogens
    • 8.3.3. Progesterones
    • 8.3.4. Somatotropins
  • 8.4. Ionophores
  • 8.5. Phytogenics
    • 8.5.1. Essential Oils
    • 8.5.2. Herbal Extracts
    • 8.5.3. Spices
  • 8.6. Prebiotics
    • 8.6.1. Fructo Oligosaccharides
    • 8.6.2. Galacto Oligosaccharides
    • 8.6.3. Mannan Oligosaccharides
  • 8.7. Probiotics
    • 8.7.1. Bacillus
    • 8.7.2. Bifidobacterium
    • 8.7.3. Lactobacillus

9. Animal Growth Promoters Market, by Animal Type

  • 9.1. Aquatic Animals
  • 9.2. Cattle
  • 9.3. Poultry
  • 9.4. Swine

10. Animal Growth Promoters Market, by Application

  • 10.1. Disease Prevention
  • 10.2. Growth Promotion
  • 10.3. Reproduction

11. Animal Growth Promoters Market, by Form

  • 11.1. Granules
  • 11.2. Liquid
  • 11.3. Pellets
  • 11.4. Powder

12. Animal Growth Promoters Market, by Mode Of Administration

  • 12.1. Feed Additive
  • 12.2. Injectable
  • 12.3. Water Additive

13. Animal Growth Promoters Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online Retail
  • 13.4. Veterinary Hospitals

14. Animal Growth Promoters Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Animal Growth Promoters Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Animal Growth Promoters Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Archer Daniels Midland Company
    • 17.3.2. Cargill, Incorporated
    • 17.3.3. BASF SE
    • 17.3.4. Koninklijke DSM N.V.
    • 17.3.5. Evonik Industries AG
    • 17.3.6. Novus International, Inc.
    • 17.3.7. Kemin Industries, Inc.
    • 17.3.8. Alltech, Inc.
    • 17.3.9. Phibro Animal Health Corporation
    • 17.3.10. Nutreco N.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ANIMAL GROWTH PROMOTERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ANIMAL GROWTH PROMOTERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL GROWTH PROMOTERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 306. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2025-2032 (USD MILLION)
  • TABLE 311. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2024 (USD MILLION)
  • TABLE 312. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2025-2032 (USD MILLION)
  • TABLE 313. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 314. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY